{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:47Z","timestamp":1792788287791,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Xinjiang Uygur Autonomous Region Tianshan Talent Training Program","award":["2023TSYCCX0060"],"award-info":[{"award-number":["2023TSYCCX0060"]}]},{"DOI":"10.13039\/100009110","name":"Natural Science Foundation of Xinjiang Uygur Autonomous Region","doi-asserted-by":"publisher","award":["2022D01D77"],"award-info":[{"award-number":["2022D01D77"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02236-6","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T13:02:47Z","timestamp":1747486967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prkci promotes colorectal cancer metastasis by phosphorylating and stabilizing Tgfbr1 to activate TGF-\u03b2 signaling"],"prefix":"10.1186","volume":"23","author":[{"given":"Peng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangshi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,17]]},"reference":[{"issue":"3","key":"2236_CR1","first-page":"233","volume":"35","author":"M Mi","year":"2023","unstructured":"Mi M, Weng S, Xu Z, Hu H, Wang Y, Yuan Y. CSCO guidelines for colorectal cancer version 2023: updates and insights. Chin J Cancer Res. 2023;35(3):233\u20138.","journal-title":"Chin J Cancer Res"},{"issue":"2","key":"2236_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrclinonc.2017.185","volume":"15","author":"A Puccini","year":"2018","unstructured":"Puccini A, Lenz HJ. Colorectal cancer in 2017: Practice-changing updates in the adjuvant and metastatic setting. Nat Rev Clin Oncol. 2018;15(2):77\u20138.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2236_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-021-00261-6","volume":"7","author":"DI Tsilimigras","year":"2021","unstructured":"Tsilimigras DI, Brodt P, Clavien PA, Muschel RJ, D\u2019Angelica MI, Endo I, et al. Liver metastases. Nat Rev Dis Primers. 2021;7(1):27.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"2236_CR4","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41571-021-00495-z","volume":"18","author":"F Di Nicolantonio","year":"2021","unstructured":"Di Nicolantonio F, Vitiello PP, Marsoni S, Siena S, Tabernero J, Trusolino L, et al. Precision oncology in metastatic colorectal cancer - from biology to medicine. Nat Rev Clin Oncol. 2021;18(8):506\u201325.","journal-title":"Nat Rev Clin Oncol"},{"key":"2236_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2023.10.004","volume":"97","author":"X Wang","year":"2023","unstructured":"Wang X, Eichhorn PJA, Thiery JP. TGF-beta, EMT, and resistance to anti-cancer treatment. Semin Cancer Biol. 2023;97:1\u201311.","journal-title":"Semin Cancer Biol"},{"key":"2236_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2024.04.001","volume":"101","author":"YE Zhang","year":"2024","unstructured":"Zhang YE, Stuelten CH. Alternative splicing in EMT and TGF-beta signaling during cancer progression. Semin Cancer Biol. 2024;101:1\u201311.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"2236_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/cr.2008.316","volume":"19","author":"D Padua","year":"2009","unstructured":"Padua D, Massague J. Roles of TGFbeta in metastasis. Cell Res. 2009;19(1):89\u2013102.","journal-title":"Cell Res"},{"issue":"7","key":"2236_CR8","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.1002\/ctm2.160","volume":"10","author":"DL Marvin","year":"2020","unstructured":"Marvin DL, Heijboer R, Ten Dijke P, Ritsma L. TGF-beta signaling in liver metastasis. Clin Transl Med. 2020;10(7):e160.","journal-title":"Clin Transl Med"},{"issue":"2","key":"2236_CR9","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1053\/j.gastro.2021.04.064","volume":"161","author":"NR Gough","year":"2021","unstructured":"Gough NR, Xiang X, Mishra L. TGF-beta signaling in liver, pancreas, and Gastrointestinal diseases and Cancer. Gastroenterology. 2021;161(2):434\u201352. e15.","journal-title":"Gastroenterology"},{"issue":"1","key":"2236_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","volume":"18","author":"R Derynck","year":"2021","unstructured":"Derynck R, Turley SJ, Akhurst RJ. TGFbeta biology in cancer progression and immunotherapy. Nat Rev Clin Oncol. 2021;18(1):9\u201334.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2236_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1053\/j.gastro.2016.10.015","volume":"152","author":"B Jung","year":"2017","unstructured":"Jung B, Staudacher JJ, Beauchamp D. Transforming growth factor beta superfamily signaling in development of colorectal Cancer. Gastroenterology. 2017;152(1):36\u201352.","journal-title":"Gastroenterology"},{"key":"2236_CR12","doi-asserted-by":"publisher","first-page":"1389136","DOI":"10.3389\/fonc.2024.1389136","volume":"14","author":"L Qu","year":"2024","unstructured":"Qu L, Xin Y, Feng J, Ren X, Li Z, Chen X, et al. Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt\/mTOR signaling pathway. Front Oncol. 2024;14:1389136.","journal-title":"Front Oncol"},{"issue":"1","key":"2236_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s10020-023-00648-z","volume":"29","author":"J Jiao","year":"2023","unstructured":"Jiao J, Ruan L, Cheng CS, Wang F, Yang P, Chen Z. Paired protein kinases PRKCI-RIPK2 promote pancreatic cancer growth and metastasis via enhancing NF-kappaB\/JNK\/ERK phosphorylation. Mol Med. 2023;29(1):47.","journal-title":"Mol Med"},{"key":"2236_CR14","doi-asserted-by":"publisher","first-page":"887139","DOI":"10.3389\/fonc.2022.887139","volume":"12","author":"Z Wu","year":"2022","unstructured":"Wu Z, Huang C, Li R, Li H, Lu H, Lin Z. PRKCI mediates radiosensitivity via the Hedgehog\/GLI1 pathway in cervical Cancer. Front Oncol. 2022;12:887139.","journal-title":"Front Oncol"},{"issue":"4","key":"2236_CR15","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/onc.2016.224","volume":"36","author":"Y Wang","year":"2017","unstructured":"Wang Y, Justilien V, Brennan KI, Jamieson L, Murray NR, Fields AP. PKCiota regulates nuclear YAP1 localization and ovarian cancer tumorigenesis. Oncogene. 2017;36(4):534\u201345.","journal-title":"Oncogene"},{"issue":"1","key":"2236_CR16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41392-020-0197-8","volume":"5","author":"H Rehmani","year":"2020","unstructured":"Rehmani H, Li Y, Li T, Padia R, Calbay O, Jin L, et al. Addiction to protein kinase ci due to PRKCI gene amplification can be exploited for an aptamer-based targeted therapy in ovarian cancer. Signal Transduct Target Ther. 2020;5(1):140.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"2236_CR17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1159\/000521588","volume":"89","author":"A Abdelatty","year":"2022","unstructured":"Abdelatty A, Fang D, Wei G, Wu F, Zhang C, Xu H, et al. PKCiota is a promising prognosis biomarker and therapeutic target for pancreatic Cancer. Pathobiology. 2022;89(6):370\u201381.","journal-title":"Pathobiology"},{"issue":"2","key":"2236_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ccr.2014.01.008","volume":"25","author":"V Justilien","year":"2014","unstructured":"Justilien V, Walsh MP, Ali SA, Thompson EA, Murray NR, Fields AP. The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma. Cancer Cell. 2014;25(2):139\u201351.","journal-title":"Cancer Cell"},{"issue":"2","key":"2236_CR19","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbrc.2016.01.059","volume":"470","author":"L Qu","year":"2016","unstructured":"Qu L, Li G, Xia D, Hongdu B, Xu C, Lin X, et al. PRKCI negatively regulates autophagy via PIK3CA\/AKT-MTOR signaling. Biochem Biophys Res Commun. 2016;470(2):306\u201312.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"2236_CR20","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1101\/gad.296640.117","volume":"31","author":"S Sarkar","year":"2017","unstructured":"Sarkar S, Bristow CA, Dey P, Rai K, Perets R, Ramirez-Cardenas A, et al. PRKCI promotes immune suppression in ovarian cancer. Genes Dev. 2017;31(11):1109\u201321.","journal-title":"Genes Dev"},{"key":"2236_CR21","doi-asserted-by":"crossref","unstructured":"Inman KS, Liu Y, Scotti Buzhardt ML, Leitges M, Krishna M, Crawford HC et al. Prkci regulates autophagy and pancreatic tumorigenesis in mice. Cancers (Basel). 2022;14(3).","DOI":"10.3390\/cancers14030796"},{"issue":"2","key":"2236_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ccell.2019.07.002","volume":"36","author":"N Yin","year":"2019","unstructured":"Yin N, Liu Y, Khoor A, Wang X, Thompson EA, Leitges M, et al. Protein kinase Ciota and Wnt\/beta-Catenin signaling: alternative pathways to Kras\/Trp53-Driven lung adenocarcinoma. Cancer Cell. 2019;36(2):156\u201367. e7.","journal-title":"Cancer Cell"},{"issue":"6","key":"2236_CR23","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.ccell.2019.11.007","volume":"36","author":"N Yin","year":"2019","unstructured":"Yin N, Liu Y, Khoor A, Wang X, Thompson EA, Leitges M, et al. Protein kinase Ciota and Wnt\/beta-Catenin signaling: alternative pathways to Kras\/Trp53-Driven lung adenocarcinoma. Cancer Cell. 2019;36(6):692\u20133.","journal-title":"Cancer Cell"},{"issue":"1","key":"2236_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13073-022-01093-z","volume":"14","author":"R Wang","year":"2022","unstructured":"Wang R, Li J, Zhou X, Mao Y, Wang W, Gao S, et al. Single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer tumors. Genome Med. 2022;14(1):93.","journal-title":"Genome Med"},{"key":"2236_CR25","doi-asserted-by":"crossref","unstructured":"Bartha A, Gyorffy B. TNMplot.com: A web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int J Mol Sci. 2021;22(5).","DOI":"10.3390\/ijms22052622"},{"issue":"6","key":"2236_CR26","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00109-009-0467-y","volume":"87","author":"E Staub","year":"2009","unstructured":"Staub E, Groene J, Heinze M, Mennerich D, Roepcke S, Klaman I, et al. An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types. J Mol Med (Berl). 2009;87(6):633\u201344.","journal-title":"J Mol Med (Berl)"},{"issue":"2","key":"2236_CR27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1158\/0008-5472.CAN-19-1161","volume":"80","author":"S Ferrandon","year":"2020","unstructured":"Ferrandon S, DeVecchio J, Duraes L, Chouhan H, Karagkounis G, Davenport J, et al. CoA synthase (COASY) mediates radiation resistance via PI3K signaling in rectal Cancer. Cancer Res. 2020;80(2):334\u201346.","journal-title":"Cancer Res"},{"issue":"4","key":"2236_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jamcollsurg.2015.12.012","volume":"222","author":"EA Levine","year":"2016","unstructured":"Levine EA, Votanopoulos KI, Qasem SA, Philip J, Cummins KA, Chou JW, et al. Prognostic molecular subtypes of Low-Grade Cancer of the appendix. J Am Coll Surg. 2016;222(4):493\u2013503.","journal-title":"J Am Coll Surg"},{"issue":"3","key":"2236_CR29","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1053\/j.gastro.2009.11.005","volume":"138","author":"JJ Smith","year":"2010","unstructured":"Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, Jiang A, et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology. 2010;138(3):958\u201368.","journal-title":"Gastroenterology"},{"issue":"9","key":"2236_CR30","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1242\/dmm.030403","volume":"10","author":"L Gomez-Cuadrado","year":"2017","unstructured":"Gomez-Cuadrado L, Tracey N, Ma R, Qian B, Brunton VG. Mouse models of metastasis: progress and prospects. Dis Model Mech. 2017;10(9):1061\u201374.","journal-title":"Dis Model Mech"},{"issue":"3","key":"2236_CR31","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/onc.2012.46","volume":"32","author":"K Kikuchi","year":"2013","unstructured":"Kikuchi K, Soundararajan A, Zarzabal LA, Weems CR, Nelon LD, Hampton ST, et al. Protein kinase C Iota as a therapeutic target in alveolar rhabdomyosarcoma. Oncogene. 2013;32(3):286\u201395.","journal-title":"Oncogene"},{"issue":"7","key":"2236_CR32","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1158\/2159-8290.CD-20-1531","volume":"11","author":"M Avolio","year":"2021","unstructured":"Avolio M, Trusolino L. Rational treatment of metastatic colorectal cancer: A reverse Tale of men, mice, and culture dishes. Cancer Discov. 2021;11(7):1644\u201360.","journal-title":"Cancer Discov"},{"issue":"1","key":"2236_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12951-025-03129-z","volume":"23","author":"YT Yen","year":"2025","unstructured":"Yen YT, Zhang Z, Chen A, Qiu Y, Liu Q, Wang Q, et al. Enzymatically responsive nanocarriers targeting PD-1 and TGF-beta pathways reverse immunotherapeutic resistance and elicit robust therapeutic efficacy. J Nanobiotechnol. 2025;23(1):124.","journal-title":"J Nanobiotechnol"},{"issue":"3","key":"2236_CR34","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/HEP.0000000000000965","volume":"81","author":"DY Oh","year":"2025","unstructured":"Oh DY, Ikeda M, Lee CK, Rojas C, Hsu CH, Kim JW, et al. Bintrafusp Alfa and chemotherapy as first-line treatment in biliary tract cancer: A randomized phase 2\/3 trial. Hepatology. 2025;81(3):823\u201336.","journal-title":"Hepatology"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02236-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02236-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02236-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T07:58:34Z","timestamp":1747987114000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02236-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2236"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02236-6","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,17]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Affiliation 1 has been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Committee of the People\u2019s Hospital of Xinjiang Uygur Autonomous Region, and all participants provided written informed consent. Animal experiments were conducted following protocols approved by the Institutional Animal Care and Use Committee at the same institution.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed and consented to the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"230"}}